CAM
RDHL

Claret Asset Management’s Redhill Biopharma RDHL Stock Holding History

Claret Asset Management’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-228
Closed -$32K – 158
2022
Q4 		$32K Buy
228
+133
+140% +$57.6K 0.01% 148
2022
Q3 		$48K Hold
95
– – 0.01% 149
2022
Q2 		$83K Hold
95
– – 0.02% 149
2022
Q1 		$240K Hold
95
– – 0.05% 136
2021
Q4 		$246K Buy
95
+32
+51% +$128K 0.05% 134
2021
Q3 		$287K Buy
63
+8
+15% +$54.3K 0.05% 133
2021
Q2 		$378K Hold
55
– – 0.06% 128
2021
Q1 		$402K Hold
55
– – 0.07% 121
2020
Q4 		$444K Buy
55
+10
+22% +$89.9K 0.09% 115
2020
Q3 		$460K Hold
45
– – 0.1% 106
2020
Q2 		$301K Sell
45
-25
-36% -$172K 0.07% 133
2020
Q1 		$317K Sell
70
-5
-7% -$25K 0.09% 115
2019
Q4 		$456K Hold
75
– – 0.09% 119
2019
Q3 		$529K Buy
75
+13
+21% +$94.6K 0.11% 100
2019
Q2 		$400K Sell
62
-6
-9% -$46.2K 0.08% 124
2019
Q1 		$561K Hold
68
– – 0.11% 100
2018
Q4 		$375K Buy
68
+20
+42% +$153K 0.08% 116
2018
Q3 		$420K Hold
48
– – 0.08% 122
2018
Q2 		$405K Hold
48
– – 0.08% 119
2018
Q1 		$246K Buy
48
+5
+12% +$28.8K 0.06% 139
2017
Q4 		$219K Buy
+43
New +$290K 0.05% 145

Other funds holding RDHL

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Claret Asset Management's RDHL Position: Q1 2023 in Review

Claret Asset Management sold out of Redhill Biopharma (RDHL) in Q1 2023, closing a stake of 228 shares — an estimated $32K sold.

Claret Asset Management first reported a position in RDHL in Q4 2017 and held it in 21 quarters. The position peaked at $561K in Q1 2019. 16 funds tracked by Wall St. Rank hold RDHL as of Q1 2023.

  • Claret Asset Management reported no remaining Redhill Biopharma position as of Q1 2023 after selling out during the quarter.
  • Claret Asset Management sold 228 Redhill Biopharma shares in Q1 2023, an estimated $32K.
  • Claret Asset Management first reported a position in Redhill Biopharma in Q4 2017 and held it in 21 quarters.
  • Claret Asset Management's Redhill Biopharma position peaked at $561K in Q1 2019.
  • 16 funds tracked by Wall St. Rank held Redhill Biopharma as of Q1 2023.

Based on Claret Asset Management's 13F filing for Q1 2023, filed 18 Apr 2023.